Elefante Mark B Novo Nordisk A S Transaction History
Elefante Mark B
- $126 Billion
- Q1 2025
A detailed history of Elefante Mark B transactions in Novo Nordisk A S stock. As of the latest transaction made, Elefante Mark B holds 9,265 shares of NVO stock, worth $596,388. This represents 0.51% of its overall portfolio holdings.
Number of Shares
9,265
Previous 3,600
157.36%
Holding current value
$596,388
Previous $310 Million
107.76%
% of portfolio
0.51%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
329MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.21 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$952 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$797 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$793 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$764 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $145B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...